Fludarabine
Hemoglobin SC
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversitySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Hemoglobin SC cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Romidepsin Tami D. John | Phase 2 | CCC |
Busulphan Tami D. John | Phase 2 | CCC |
Mesna Tami D. John | N/A | D |
Cyclophosphamide Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A | D |
Campath 1H Tami D. John | N/A | D |
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →